Modest weight gain is associated with sympathetic neural activation in nonobese humans

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 5, 2007, Pages

  Gentile, Christopher L ^a   Orr, Jeb S ^a   Davy, Brenda M ^a   Davy, Kevin P ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Adiposity; Autonomic nervous system; Overfeeding

Indexed keywords

RENIN;

ABDOMINAL FAT; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CALORIC INTAKE; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE INNERVATION; NERVE CONDUCTION; NEUROGRAPHY; NORMAL HUMAN; PRIORITY JOURNAL; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN;

ADULT; DIET; HUMANS; MALE; SYMPATHETIC NERVOUS SYSTEM; WEIGHT GAIN;

EID: 34248178259     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00876.2006     Document Type: Article

References (37)

1. Alvarez GE, Ballard TP, Beske SD, Davy KP. Subcutaneous obesity is not associated with sympathetic neural activation. Am J Physiol Heart Circ Physiol 287: H414-H418, 2004.
2. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 106: 2533-2536, 2002.
3. Charkoudian N, Joyner MJ, Sokolnicki LA, Johnson CP, Eisenach JH, Dietz NM, Curry TB, Wallin BG. Vascular adrenergic responsiveness is inversely related to tonic activity of sympathetic vasoconstrictor nerves in humans. J Physiol 572: 821-827, 2006.
4. Cohn JN, Pfeffer MA, Rouleau J, Sharpe N, Swedberg K, Straub M, Wiltse C, Wright TJ. Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON). Eur J Heart Fail 5: 659-667, 2003.
5. Davy KP, Seals DR, Tanaka H. Augmented cardiopulmonary and integrative baroreflexes but attenuated peripheral vasoconstriction with age. Hypertension 32: 298-304, 1998.
6. Davy KP, Hall JE. Obesity and hypertension: two epidemics or one? Am J Physiol Regul Integr Comp Physiol 286: R803-R813, 2004.
7. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 70: 963-985, 1990.
8. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens 17: 719-734, 1999.
9. Grassi G, Seravalle G, Colombo M, Bolla G, Cattaneo B, Cavagnini F, Mancia G. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 97: 2037-2042, 1998.
10. Grassi G, Seravalle G, Dell'Oro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 36: 538-542, 2000.
11. Gudbjornsdottir S, Lonnroth P, Sverrisdottir Y, Wallin B, Elam M. Sympathetic nerve activity and insulin in obese normotensive and hypertensive men. Hypertension 27: 276-280, 1996.
12. Hall JE. The kidney, hypertension, and obesity. Hypertension 41: 625-633, 2003.
13. Hall JE, Kuo JJ, Da Silva AA, De Paula RB, Liu J, Tallam L. Obesity-associated hypertension and kidney disease. Curr Opin Nephrol Hypertens 12: 195-200, 2003.
14. Huggett RJ, Scott EM, Gilbey SG, Bannister J, Mackintosh AF, Mary DA. Disparity of autonomic control in type 2 diabetes mellitus. Diabetologia 48: 172-179, 2005.
15. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 26: 1257-1263, 1995.
16. Landsberg L. Diet, obesity and hypertension: a hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. QJM 61: 1081-1090, 1986.
17. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 19: 523-528, 2001.
18. Leibel R, Rosenbaum M, Hirsh J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 332: 621-628, 1995.
19. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42: 474-480, 2003.
20. Masuo K, Mikami H, Ogihara T, Tuck ML. Weight gain-induced blood pressure elevation. Hypertension 35: 1135-1140, 2000.
21. Morrison SF. Differential control of sympathetic outflow. Am J Physiol Regul Integr Comp Physiol 281: R683-R698, 2001.
22. O'Dea K, Esler M, Leonard P, Stockigt J, Nestel P. Noradrenaline turnover during under- and over-eating in normal weight subjects. Metabolism 31: 896-899, 1982.
23. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334: 1349-1355, 1996.
24. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 277: 739-745, 1997.
25. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP, Esler MD. Neural mechanisms in human obesity-related hypertension. J Hypertens 17: 1125-1133, 1999.
26. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 108: 560-565, 2003.
27. Spraul M, Anderson EA, Bogardus C, Ravussin E. Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat. Diabetes 43: 191-196, 1994.
28. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 92: 1730-1735, 1993.
29. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 90: 5998-6005, 2005.
30. Tamaya-Mori N, Uemura K, Iguchi A. Gender differences in the dietary lard-induced increase in blood pressure in rats. Hypertension 39: 1015-1020, 2002.
31. Tamaya-Mori N, Uemura K, Tanaka S, Iguchi A. Aging accelerates dietary lard-induced increase in blood pressure in rats. Exp Gerontol 38: 905-910, 2003.
32. Trombetta IC, Batalha LT, Rondon MU, Laterza MC, Kuniyoshi FH, Gowdak MM, Barretto AC, Halpern A, Villares SM, Negrao CE. Weight loss improves neurovascular and muscle metaboreflex control in obesity. Am J Physiol Heart Circ Physiol 285: H974-H982, 2003.
33. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 96: 3423-3429, 1997.
34. Wallin B, Kunimoto M, Sellgren J. Possible genetic influence on the strength of human muscle nerve sympathetic activity at rest. Hypertension 22: 282-284, 1993.
35. Wallin BG, Fagius J. Peripheral sympathetic neural activity in conscious humans. Annu Rev Physiol 50: 565-576, 1988.
36. Weyer C, Pratley RE, Snitker S, Spraul M, Ravussin E, Tataranni PA. Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure. Hypertension 36: 531-537, 2000.
37. Young J, Macdonald I. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes 16: 959-967, 1992.